To further corroborate the in vitro cell lines data, we evaluated MAO-A expression in a total of 288 blood circulating tumor cells (CTCs) samples collected from men with mCRPC undergoing treatment with standard-of-care systemic therapies. The gene discussed is MAOA; the disease is neoplasm.